Search in:

Advanced search

Journal of Medical Economics Volume 25, 2022 - Issue 1

Submit an article Journal homepage

Open access

1,314

Views

CrossRef citations to date

Altmetric

Oncology

Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA

Michael Blankenburga Bayer AG, Berlin, GermanyCorrespondence[email protected]

Mostafa Elhamamya Bayer AG, Berlin, Germany

Diana Zhangb Department of Pharmaceuticals, Bayer Healthcare Company Limited, Beijing, China

Alice Corbinc Wickenstones Ltd., Carlow, Ireland

Guanyi Jinc Wickenstones Ltd., Carlow, Ireland

James Harrisc Wickenstones Ltd., Carlow, Ireland

Gesine Knoblocha Bayer AG, Berlin, Germany

show all

Pages 1015-1029 | Received 14 Dec 2021, Accepted 03 Aug 2022, Published online: 19 Aug 2022

Cite this article
https://doi.org/10.1080/13696998.2022.2110353
CrossMark

Full Article
Figures & data
References
Supplemental
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF View EPUB EPUB

References

Globocan 2020. Liver cancer fact sheet; 2020. Available from: https://gco.iarc.fr/today/data/factsheets/cancers/11-Liver-fact-sheet.pdf
Google Scholar
Villanueva A. Hepatocellular carcinoma. N Engl J Med. 2019;380(15):1450–1462.
PubMed Web of Science ®Google Scholar
Society AC. 2021 [cited 2021 Jun 11]. Available from: https://www.cancer.org/cancer/liver-cancer/detection-diagnosis-staging/survival-rates.html
Google Scholar
Hassanipour S, Vali M, Gaffari-Fam S, et al. The survival rate of hepatocellular carcinoma in Asian countries: a systematic review and Meta-analysis. Excli J. 2020;19:108–130.
PubMed Web of Science ®Google Scholar
Weledji EP, Enow Orock G, Ngowe MN, et al. How grim is hepatocellular carcinoma? Ann Med Surg. 2014;3(3):71–76.
PubMedGoogle Scholar
Marrero JA, Kulik LM, Sirlin CB, et al. Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases. Hepatology. 2018;68(2):723–750.
PubMed Web of Science ®Google Scholar
Zhou J, Sun H, Wang Z, et al. Guidelines for the diagnosis and treatment of hepatocellular carcinoma (2019 edition). Liver Cancer. 2020;9(6):682–720.
PubMed Web of Science ®Google Scholar
Chou R, Cuevas C, Fu R, et al. Imaging techniques for the diagnosis of hepatocellular carcinoma. Ann Intern Med. 2015;162(10):697–711.
PubMed Web of Science ®Google Scholar
Roberts LR, Sirlin CB, Zaiem F, et al. Imaging for the diagnosis of hepatocellular carcinoma: a systematic review and meta-analysis. Hepatology. 2018;67(1):401–421.
PubMed Web of Science ®Google Scholar
He X, Wu J, Holtorf AP, et al. Health economic assessment of Gd-EOB-DTPA MRI versus ECCM-MRI and multi-detector CT for diagnosis of hepatocellular carcinoma in China. PLOS One. 2018;13(1):e0191095.
PubMed Web of Science ®Google Scholar
Nishie A, Goshima S, Haradome H, et al. Cost-effectiveness of EOB-MRI for hepatocellular carcinoma in Japan. Clin Ther. 2017;39(4):738–750.e4.
PubMed Web of Science ®Google Scholar
Lee JM, Kim MJ, Phongkitkarun S, et al. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea. J Med Econ. 2016;19(8):759–768.
PubMed Web of Science ®Google Scholar
Briggs AH, Weinstein MC, Fenwick EA, et al. Model parameter estimation and uncertainty analysis: a report of the ISPOR-SMDM modeling good research practices task force working group-6. Med Decis Making. 2012;32(5):722–732.
PubMed Web of Science ®Google Scholar
Zhang J, Yu Y, Li Y, et al. Diagnostic value of contrast-enhanced ultrasound in hepatocellular carcinoma: a meta-analysis with evidence from 1998 to 2016. Oncotarget. 2017;8(43):75418–75426.
PubMedGoogle Scholar
Medicare provider utilization and payment data: physician and other supplier PUF CY2017; 2017. Available from: https://data.cms.gov/Medicare-Physician-Supplier/Medicare-Provider-Utilization-and-Payment-Data-Phy/fs4p-t5eq/data
Google Scholar
RED BOOK online from micromedex. Available from: http://www.micromedexsolutions.com/
Google Scholar
Goossens N, Singal AG, King LY, et al. Cost-effectiveness of risk score-stratified hepatocellular carcinoma screening in patients with cirrhosis. Clin Transl Gastroenterol. 2017;8(6):e101.
PubMed Web of Science ®Google Scholar
Chen H, Chen L. Estimating cost-effectiveness associated with all-oral regimen for chronic hepatitis C in China. PLOS One. 2017;12(4):e0175189.
PubMed Web of Science ®Google Scholar
Lima PH, Fan B, Bérubé J, et al. Cost-utility analysis of imaging for surveillance and diagnosis of hepatocellular carcinoma. Am J Roentgenol. 2019;213(1):17–25.
PubMed Web of Science ®Google Scholar
Lin Y-J, Lin C-N, Sedghi T, et al. Treatment patterns and survival in hepatocellular carcinoma in the United States and Taiwan. PLOS One. 2020;15(10):e0240542.
PubMed Web of Science ®Google Scholar
Singal AG, Waljee AK, Patel N, et al. Therapeutic delays lead to worse survival among patients with hepatocellular carcinoma. J Natl Compr Canc Netw. 2013;11(9):1101–1108.
PubMed Web of Science ®Google Scholar
Kim HD, Lim YS, Han S, et al. Evaluation of early-stage hepatocellular carcinoma by magnetic resonance imaging with gadoxetic acid detects additional lesions and increases overall survival. Gastroenterology. 2015;148(7):1371–1382.
PubMed Web of Science ®Google Scholar
Kang TW, Kong SY, Kang D, et al. Use of gadoxetic acid-enhanced liver MRI and mortality in more than 30 000 patients with hepatocellular carcinoma: a nationwide analysis. Radiology. 2020;295(1):114–124.
PubMed Web of Science ®Google Scholar
Kohn CG, Singh P, Korytowsky B, et al. Humanistic and economic burden of hepatocellular carcinoma: systematic literature review. Am J Manag Care. 2019;25(2 Spec No):sp61–sp73.
PubMedGoogle Scholar

Share icon
Back to Top

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Evaluation of the health economic impact of initial diagnostic modality selection in patients suspected of having HCC in China and the USA

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date